Lepu Medical Technology (Beijing) Co., Ltd. engages in the development, manufacture, and distribution of medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters and Angiocide peripheral cutting balloons; and cardiovascular products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, fractional flow reserves, and accessories. It also provides digital subtraction angiography systems, such as Vicor-CV Robin C/F digital subtraction angiography systems and Vicor-CV SWIFT medical angiography x-ray systems; congenital heart disease products; cardiac rhythm management products that comprise electrophysiology, pacemakers and leads, and equipment; ECG, patient monitors, and oximeters; home medical equipment, such as oxygen generators, nebulizers, sphygmomanometers, infrared and digital thermometers, measuring instrument, fingerpulse pulse oximeters, and eye massage instruments; critical care products; dialyzers, hemoperfutor, and hemodialysis accessories; in vitro diagnostics comprising hematology, point of care testing, immunoassay, molecular diagnostics, and biochemistry; surgical products, which include ultrasonic surgical system, surgical stapler, endoscopic ultrasound system; portable, trolley, and veterinary ultrasound products; oncology diagnostics; and orthopedic products. In addition, the company offers APIs and FDFs for cardiovascular, anti-infectives, oncology, central nervous system, and other diseases; and offers skin care products under the LEPU LAB brand name; and polymerase chain reaction solutions, SARS-CoV-2 test kits, infrared forehead thermometers, patient monitors, pulse oximeters, sterile syringes, and neutralization antibody test kits. Further, it engages in investment, technology development, aged care, and trading businesses. Lepu Medical Technology (Beijing) Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.